Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Health Care Sector · Mutual

LYFAX Holdings: What AlphaCentric Life Sciences and Healthcare Fund Owns

Ticker LYFAX · Since 2019-11-29 · · Holdings as of Jun 30, 2026

Expense ratio
1.66%$166/yr per $10k
5-yr return
+4.1%annualized
1-yr return
+20.6%as of Dec 2025
Net assets
$46.6Mall share classes
Holdings
62

Bottom line

What does LYFAX hold?

LYFAX held 62 positions as of Jun 30, 2026. Its largest holding is Gilead Sciences Inc at 5.53% of the fund, and the top 10 positions add up to 40.7%. By asset type it is 96% stocks, 4% cash & short-term funds.

Updated Aug 27, 2026

LYFAX top 25 holdings

#HoldingType% of fundValue
1 Gilead Sciences Inc
GILEAD SCIENCES
Stocks 5.53%$2.6M
2 Vertex Pharmaceuticals Inc
VERTEX PHARM
Stocks 5.33%$2.5M
3 Astrazeneca Plc Stocks 4.63%$2.2M
4 First American Funds Inc
FIRST AM-TR OB-X
Cash & short-term funds 4.26%$2.0M
5 Roivant Sciences Ltd
ROIVANT SCIENCES
Stocks 3.67%$1.7M
6 Argenx Se
ARGENX SE - ADR
Stocks 3.59%$1.7M
7 Neurocrine Biosciences Inc
NEUROCRINE BIOSC
Stocks 3.51%$1.6M
8 Incyte Corp Stocks 3.51%$1.6M
9 Axsome Therapeutics Inc
AXSOME THERAPEUT
Stocks 3.43%$1.6M
10 Apogee Therapeutics Inc
APOGEE THERAPEUT
Stocks 3.28%$1.5M
11 Ionis Pharmaceuticals Inc
IONIS PHARMACEUT
Stocks 2.62%$1.2M
12 Ascendis Pharma A/s
ASCENDIS PHARMA
Stocks 2.62%$1.2M
13 Insmed Inc Stocks 2.60%$1.2M
14 Protagonist Therapeutics Inc
PROTAGONIST THER
Stocks 2.41%$1.1M
15 Personalis Inc Stocks 2.27%$1.1M
16 Rhythm Pharmaceuticals Inc
RHYTHM PHARMACEU
Stocks 2.25%$1.0M
17 Abbvie Inc Stocks 1.95%$909.2K
18 Jazz Pharmaceuticals Plc
JAZZ PHARMACEUTI
Stocks 1.87%$870.6K
19 Amgen Inc Stocks 1.83%$855.3K
20 Biogen Inc Stocks 1.80%$840.7K
21 Catalyst Pharmaceuticals Inc
CATALYST PHARMAC
Stocks 1.59%$742.4K
22 Halozyme Therapeutics Inc
HALOZYME THERAPE
Stocks 1.58%$737.8K
23 Meiragtx Holdings Plc
MEIRAGTX HOLDING
Stocks 1.58%$735.9K
24 Krystal Biotech Inc
KRYSTAL BIOTECH
Stocks 1.55%$722.9K
25 Nuvalent Inc
NUVALENT INC-A
Stocks 1.47%$686.4K

Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 27, 2026

Asset mix

Stocks95.8%
Cash & short-term funds4.3%

Country exposure

BM3.7%
DE1.3%
DK2.6%
FR2.8%
GB4.6%
IE2.4%
KY1.6%
NL4.7%
SG0.4%
US76.0%